Cory SagoHead of Platform Research at Guide Therapeutics
Cory Sago is the Head of Platform Research and co-founder at Guide Therapeutics, a gene therapy company based in Atlanta, Georgia. Guide Therapeutics utilizes a proprietary technology that enables the high throughput screening of lipid nanoparticles in vivo to discover LNPs with novel and improved tropisms. He received his PhD from Georgia Tech and Emory University, where he developed the high throughput nanoparticle screening technologies utilized by Guide Therapeutics. This work has led to publications in PNAS, JACS, ACS Nano, Nano Letters, Advanced Materials and other peer-reviewed journals.